Cutting-edge prevention drugs - hailed as being able to reduce new infections to zero - could see the end of the Aids ...

One of the world’s biggest funders of the fight against HIV, tuberculosis and malaria faces reduced funding for life-saving work over the next three years.

The STDC receives highly infectious TB samples from western Maharashtra for laboratory testing, research and analysis ...

The Global TB Report 2025 released by the World Health Organization (WHO) highlights that India’s TB incidence has reduced ...

Initial blood work found hints of an infection, and the doctors initially suspected a bacterial skin infection (cellulitis) ...

By Sharon Atieno With tuberculosis (TB) treatment lasting about six to nine months, a new treatment regimen is set to reduce this period.A phase two clinical trial by TB Alliance has showed that a new ...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...